Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance

被引：0
|
作者：
Yee Soo Kim
Simerjeet Brar
Natalie D’Albo
Amit Dey
Sachin Shah
Sarju Ganatra
Sourbha S. Dani
机构：
[1] Lahey Hospital and Medical Center,Department of Internal Medicine
[2] Georgetown University Medical Center,Department of Internal Medicine
[3] Lahey Hospital and Medical Center,Beth Israel Lahey Health, Department of Cardiovascular Medicine
来源：
Cardiovascular Drugs and Therapy | 2022年 / 36卷
关键词：
Sacubitril/valsartan; FDA Adverse Event Reporting System; Real-world pharmacovigilance; Disproportionality analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：915 / 924
页数：9
相关论文
共 50 条
  • [21] Effect of sacubitril/valsartan in real-world patients in South London
    Holm, N. Niels
    Bromage, D.
    Decourcey, J.
    Mcdonagh, T. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 419 - 419
  • [22] Real-world use of sacubitril-valsartan in the South of England
    Dimarco, A. Anthony D.
    Haydock, P. H.
    Flett, A. S.
    Cowburn, P. J.
    Chandrasekaran, B.
    Foley, P.
    Dixon, G.
    Davis, H.
    Critoph, C.
    Jackson, T.
    Kelly, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 233 - 234
  • [23] REAL-WORLD USE OF SACUBITRIL-VALSARTAN IN THE SOUTH OF ENGLAND
    Dimarco, Anthony
    Haydock, Paul
    Flett, Andrew
    Cowburn, Peter
    Chandrasekaran, Badrinathan
    Foley, Paul
    Dixon, Giles
    Jackson, Thomas
    Critoph, Chris
    Davis, Hannah
    Kelly, Dominic
    HEART, 2020, 106 : A72 - A73
  • [24] Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results
    Garcia-Moll, Xavier
    Lopez, Laura
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 400
  • [25] Effectiveness and Safety of Sacubitril/Valsartan in Patients with Chronic Kidney Disease-A Real-World Experience
    Pereira, Sara C.
    Rodrigues, Tiago
    Nunes-Ferreira, Afonso
    Agostinho, Joao R.
    Pinto, Fausto J.
    Brito, Dulce
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [26] A real-world pharmacovigilance study of sacubitril\valsartan in older people: data mining of the FDA adverse event reporting system
    Kuai, Zheng
    Li, Quan
    Zhang, Xiaoyi
    Tang, Guowen
    Ye, Yangli
    Hu, Yu
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [27] Real-World Safety of Sacubitril/Valsartan in Women and Men With Heart Failure and Reduced Ejection Fraction: A Meta-analysis
    Nuechterlein, Kaitlin
    AlTurki, Ahmed
    Ni, Jiayi
    Martinez-Selles, Manuel
    Martens, Pieter
    Russo, Vincenzo
    Backelin, Charlotte Nordberg
    Huynh, Thao
    CJC OPEN, 2021, 3 (12) : S202 - S208
  • [28] Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
    Maria Vincenza Polito
    Angelo Silverio
    Antonella Rispoli
    Gennaro Vitulano
    Federica D’ Auria
    Elena De Angelis
    Francesco Loria
    Alberto Gigantino
    Domenico Bonadies
    Rodolfo Citro
    Albino Carrizzo
    Gennaro Galasso
    Guido Iaccarino
    Carmine Vecchione
    Michele Ciccarelli
    Scientific Reports, 10
  • [29] Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
    Polito, Maria Vincenza
    Silverio, Angelo
    Rispoli, Antonella
    Vitulano, Gennaro
    D'Auria, Federica
    De Angelis, Elena
    Loria, Francesco
    Gigantino, Alberto
    Bonadies, Domenico
    Citro, Rodolfo
    Carrizzo, Albino
    Galasso, Gennaro
    Iaccarino, Guido
    Vecchione, Carmine
    Ciccarelli, Michele
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [30] Sacubitril-Valsartan: real-world single-centre experience
    Climent, Herminio Morillas
    Lopez, Alvaro Vicedo
    Moya, Julia Seller
    Torres, Edgard Alania
    Jornet, Emilio Galcera
    Rodriguez, Ainhoa Larumbe
    Piles, Carlos Nunez
    Munoz, Alfonso Valle
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 257 - 257
12345